Small molecule activators of calcium-activated chloride channels and methods of use
作者： Alan S. Verkman , Wan Namkung
DOI:
关键词:
摘要: Provided herein are small molecule activators of calcium-activated chloride channels. These molecules may be used for treatment diseases and disorders that treatable by activating channels, such as cystic fibrosis, related to salivary gland dysfunction (for example, Sjogren's syndrome following radiation injury), dry eye syndrome, intestinal hypomotility.
lens.org 参考文章(47)
Ke Chen, Jr John K. Dickson, Carl Nicholas Hodge, Jose Serafin Mendoza, 2-Amido-Thiazole-Based Compounds Exhibiting ATP-Utilizing Enzyme Inhibitory Activity, and Compositions, and Uses Thereof ,(2005)
Alison J Davis, Jian Shi, Harry AT Pritchard, Preet S Chadha, Normand Leblanc, Georgios Vasilikostas, Zhen Yao, AS Verkman, Anthony P Albert, Iain A Greenwood, Potent vasorelaxant activity of the TMEM16A inhibitor T16Ainh‐A01 British Journal of Pharmacology. ,vol. 168, pp. 773- 784 ,(2013) , 10.1111/J.1476-5381.2012.02199.X
Alan S. Verkman, Ricardo De La Fuente Gonzalez, Inhibitors of calcium-activated chloride channels ,(2008)
Sung Jin Hwang, Peter J. A. Blair, Fiona C. Britton, Kate E. O’Driscoll, Grant Hennig, Yulia R. Bayguinov, Jason R. Rock, Brian D. Harfe, Kenton M. Sanders, Sean M. Ward, Expression of anoctamin 1/TMEM16A by interstitial cells of Cajal is fundamental for slow wave activity in gastrointestinal muscles The Journal of Physiology. ,vol. 587, pp. 4887- 4904 ,(2009) , 10.1113/JPHYSIOL.2009.176198
J. Eggermont, Calcium-activated chloride channels: (un)known, (un)loved? Proceedings of the American Thoracic Society. ,vol. 1, pp. 22- 27 ,(2004) , 10.1513/PATS.2306010
Ricardo De La Fuente, Wan Namkung, Aaron Mills, A. S. Verkman, Small-Molecule Screen Identifies Inhibitors of a Human Intestinal Calcium-Activated Chloride Channel Molecular Pharmacology. ,vol. 73, pp. 758- 768 ,(2008) , 10.1124/MOL.107.043208
A. S. Verkman, Yuanlin Song, Jay R. Thiagarajah, Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. American Journal of Physiology-cell Physiology. ,vol. 284, ,(2003) , 10.1152/AJPCELL.00417.2002
Satish Kumar, Wan Namkung, A.S. Verkman, Pawan K. Sharma, Novel 5-substituted benzyloxy-2-arylbenzofuran-3-carboxylic acids as calcium activated chloride channel inhibitors Bioorganic & Medicinal Chemistry. ,vol. 20, pp. 4237- 4244 ,(2012) , 10.1016/J.BMC.2012.05.074
Michael J. Munchhof, Amy S. Antipas, Laura C. Blumberg, William H. Brissette, Matthew F. Brown, Jeffrey M. Casavant, Jonathan L. Doty, James Driscoll, Thomas M. Harris, Lilli A. Wolf-Gouveia, Christopher S. Jones, Qifang Li, Robert G. Linde, Paul D. Lira, Anthony Marfat, Eric McElroy, Mark Mitton-Fry, Sandra P. McCurdy, Lawrence A. Reiter, Sharon L. Ripp, Andrei Shavnya, Lisa M. Thomasco, Kristen A. Trevena, The identification of orally bioavailable thrombopoietin agonists. Bioorganic & Medicinal Chemistry Letters. ,vol. 19, pp. 1428- 1430 ,(2009) , 10.1016/J.BMCL.2009.01.032
Young Duk Yang, Hawon Cho, Jae Yeon Koo, Min Ho Tak, Yeongyo Cho, Won-Sik Shim, Seung Pyo Park, Jesun Lee, Byeongjun Lee, Byung-Moon Kim, Ramin Raouf, Young Ki Shin, Uhtaek Oh, TMEM16A confers receptor-activated calcium-dependent chloride conductance Nature. ,vol. 455, pp. 1210- 1215 ,(2008) , 10.1038/NATURE07313